Skip to content
Learning About the New Definition of MASLD episode artwork

Oct 5, 2023 13 min

Learning About the New Definition of MASLD

from GI Insights

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Kwo, MD Non-alcoholic fatty liver disease connoted that there's no alcohol contribution to the fat and didn't accurately convey the interplay between metabolic-driven cytosis, which can come from insulin resistance and all of the other metabolic dysfunction-associated inflammatory patterns, as well as the contributions of alcohol. So what do we know about patients who have metabolic dysfunction-associated steatotic liver disease (MASLD) and also consume alcohol? To learn more, join Dr. Peter Buch as he discusses this with Dr. Paul Kwo, Professor of Medicine and the Director of Hepatology at Stanford University.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Learning About the New Definition of MASLD

0:00 13:29

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of GI Insights?

This episode is 13 minutes long.

When was this GI Insights episode published?

This episode was published on October 5, 2023.

Can I download this GI Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.